The use of naloxone to antagonize large doses of opiates administered during nitrous oxide anesthesia.
D000328:Adult; D000368:Aged; D000698:Analgesia; D000769:Anesthesia, Inhalation; D002245:Carbon Dioxide / Q000097:blood; D003243:Consciousness / Q000187:drug effects; D005260:Female; D005283:Fentanyl / Q000009:adverse effects*; D006801:Humans; D007263:Infusions, Parenteral; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects*; D009270:Naloxone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D009609:Nitrous Oxide; D011183:Postoperative Complications; D012131:Respiratory Insufficiency / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control
D009292:Narcotic Antagonists; D002245:Carbon Dioxide; D009270:Naloxone; D009020:Morphine; D009609:Nitrous Oxide; D005283:Fentanyl